Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

Authors:

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • Regeneron Pharmaceuticals Inc
  • Sanofi US

This publication has 22 references indexed in Scilit: